Unity Biotechnology Inc (UBX)
1.135
-0.02
(-2.16%)
USD |
NASDAQ |
Nov 22, 16:00
1.19
+0.06
(+4.85%)
After-Hours: 20:00
Unity Biotechnology Enterprise Value: -9.490M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | -9.490M |
| November 20, 2024 | -9.322M |
| November 19, 2024 | -9.490M |
| November 18, 2024 | -8.985M |
| November 15, 2024 | -8.648M |
| November 14, 2024 | -7.806M |
| November 13, 2024 | -6.963M |
| November 12, 2024 | -6.794M |
| November 11, 2024 | -7.974M |
| November 08, 2024 | -9.322M |
| November 07, 2024 | -9.154M |
| November 06, 2024 | -9.659M |
| November 05, 2024 | -8.648M |
| November 04, 2024 | -7.806M |
| November 01, 2024 | -6.963M |
| October 31, 2024 | -6.120M |
| October 30, 2024 | -5.783M |
| October 29, 2024 | -5.446M |
| October 28, 2024 | -5.446M |
| October 25, 2024 | -6.458M |
| October 24, 2024 | -6.794M |
| October 23, 2024 | -5.952M |
| October 22, 2024 | -5.446M |
| October 21, 2024 | -5.446M |
| October 18, 2024 | -5.446M |
| Date | Value |
|---|---|
| October 17, 2024 | -5.783M |
| October 16, 2024 | -5.109M |
| October 15, 2024 | -5.446M |
| October 14, 2024 | -4.435M |
| October 11, 2024 | -3.761M |
| October 10, 2024 | -4.435M |
| October 09, 2024 | -4.098M |
| October 08, 2024 | -3.930M |
| October 07, 2024 | -3.930M |
| October 04, 2024 | -4.435M |
| October 03, 2024 | -4.772M |
| October 02, 2024 | -4.941M |
| October 01, 2024 | -4.772M |
| September 30, 2024 | -4.267M |
| September 27, 2024 | -9.555M |
| September 26, 2024 | -9.724M |
| September 25, 2024 | -9.892M |
| September 24, 2024 | -9.724M |
| September 23, 2024 | -9.724M |
| September 20, 2024 | -9.555M |
| September 19, 2024 | -9.724M |
| September 18, 2024 | -10.06M |
| September 17, 2024 | -10.06M |
| September 16, 2024 | -10.23M |
| September 13, 2024 | -9.724M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-50.48M
Minimum
Mar 29 2023
527.32M
Maximum
Aug 14 2020
71.45M
Average
3.243M
Median
Jul 27 2022
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | -63.40M |
| Electromed Inc | 223.55M |
| Xtant Medical Holdings Inc | 85.83M |
| Myomo Inc | 138.56M |
| Catheter Precision Inc | 3.891M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -6.481M |
| Total Expenses (Quarterly) | 6.602M |
| EPS Diluted (Quarterly) | -0.38 |
| Earnings Yield | -111.9% |
| Normalized Earnings Yield | -834.36 |